Drug Profile
Shigella flexneri vaccine CVD 1203
Latest Information Update: 15 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Shigella infections
Most Recent Events
- 15 Jun 2001 No-Development-Reported for Shigella infections in USA (PO)
- 09 Oct 1995 New profile
- 09 Oct 1995 Phase-I clinical trials for Shigella infections in USA (PO)